Cargando…

Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments

Functional outcomes and synovial fluid (SF) cytokine concentrations in response to platelet-rich plasma (PRP) or stromal vascular fraction (SVF) post-treatments following open wedge high tibial osteotomy (HTO) in 20 patients with knee osteoarthritis (OA) were examined. Six weeks after surgery, the k...

Descripción completa

Detalles Bibliográficos
Autores principales: Prizov, Aleksey, Tchetina, Elena, Eremin, Ilya, Zagorodniy, Nikolay, Pulin, Andrey, Belyak, Evgeniy, Goncharov, Evgeniy, Kotenko, Konstantin, Smyshlyaev, Ivan, Glukhova, Svetlana, Lila, Aleksandr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657490/
https://www.ncbi.nlm.nih.gov/pubmed/36361627
http://dx.doi.org/10.3390/ijms232112835
_version_ 1784829708041453568
author Prizov, Aleksey
Tchetina, Elena
Eremin, Ilya
Zagorodniy, Nikolay
Pulin, Andrey
Belyak, Evgeniy
Goncharov, Evgeniy
Kotenko, Konstantin
Smyshlyaev, Ivan
Glukhova, Svetlana
Lila, Aleksandr
author_facet Prizov, Aleksey
Tchetina, Elena
Eremin, Ilya
Zagorodniy, Nikolay
Pulin, Andrey
Belyak, Evgeniy
Goncharov, Evgeniy
Kotenko, Konstantin
Smyshlyaev, Ivan
Glukhova, Svetlana
Lila, Aleksandr
author_sort Prizov, Aleksey
collection PubMed
description Functional outcomes and synovial fluid (SF) cytokine concentrations in response to platelet-rich plasma (PRP) or stromal vascular fraction (SVF) post-treatments following open wedge high tibial osteotomy (HTO) in 20 patients with knee osteoarthritis (OA) were examined. Six weeks after surgery, the knees of 10 patients were injected with autologous PRP (PRP subgroup), while another 10 patients were injected with autologous SVF (SVF subgroup) and monitored for 1.5 years. Pain assessment (VAS score) and functional activity (KOOS, KSS, Outerbridge, and Koshino scores) were applied. PRP subgroup performed better compared with the SVF subgroup according to KOOS, KSS, and VAS scores, while the SVF subgroup demonstrated better results according to Outerbridge and Koshino testing and produced more pronounced cartilage regeneration in the medial condyle and slowed down cartilage destruction in its lateral counterpart. SF was collected before and one week after PRP or SVF injections and tested for concentrations of 41 cytokines (Multiplex Assay). In the PRP subgroup, a significant decrease in IL-6 and CXCL10 synovial concentrations was accompanied by an increase in IL-15, sCD40L, and PDGF-AB/BB amounts. The SVF subgroup demonstrated a significant decrease in synovial TNFα, FLT-3L, MIP-1β, RANTES, and VEGF concentrations while SF concentrations of MCP-1 and FGF2 increased. Both post-treatments have a potential for increased tissue regeneration, presumably due to the downregulation of inflammation and augmentation of synovial growth factor concentrations.
format Online
Article
Text
id pubmed-9657490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96574902022-11-15 Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments Prizov, Aleksey Tchetina, Elena Eremin, Ilya Zagorodniy, Nikolay Pulin, Andrey Belyak, Evgeniy Goncharov, Evgeniy Kotenko, Konstantin Smyshlyaev, Ivan Glukhova, Svetlana Lila, Aleksandr Int J Mol Sci Article Functional outcomes and synovial fluid (SF) cytokine concentrations in response to platelet-rich plasma (PRP) or stromal vascular fraction (SVF) post-treatments following open wedge high tibial osteotomy (HTO) in 20 patients with knee osteoarthritis (OA) were examined. Six weeks after surgery, the knees of 10 patients were injected with autologous PRP (PRP subgroup), while another 10 patients were injected with autologous SVF (SVF subgroup) and monitored for 1.5 years. Pain assessment (VAS score) and functional activity (KOOS, KSS, Outerbridge, and Koshino scores) were applied. PRP subgroup performed better compared with the SVF subgroup according to KOOS, KSS, and VAS scores, while the SVF subgroup demonstrated better results according to Outerbridge and Koshino testing and produced more pronounced cartilage regeneration in the medial condyle and slowed down cartilage destruction in its lateral counterpart. SF was collected before and one week after PRP or SVF injections and tested for concentrations of 41 cytokines (Multiplex Assay). In the PRP subgroup, a significant decrease in IL-6 and CXCL10 synovial concentrations was accompanied by an increase in IL-15, sCD40L, and PDGF-AB/BB amounts. The SVF subgroup demonstrated a significant decrease in synovial TNFα, FLT-3L, MIP-1β, RANTES, and VEGF concentrations while SF concentrations of MCP-1 and FGF2 increased. Both post-treatments have a potential for increased tissue regeneration, presumably due to the downregulation of inflammation and augmentation of synovial growth factor concentrations. MDPI 2022-10-25 /pmc/articles/PMC9657490/ /pubmed/36361627 http://dx.doi.org/10.3390/ijms232112835 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Prizov, Aleksey
Tchetina, Elena
Eremin, Ilya
Zagorodniy, Nikolay
Pulin, Andrey
Belyak, Evgeniy
Goncharov, Evgeniy
Kotenko, Konstantin
Smyshlyaev, Ivan
Glukhova, Svetlana
Lila, Aleksandr
Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title_full Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title_fullStr Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title_full_unstemmed Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title_short Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments
title_sort differences in synovial cytokine profile associated with long-term clinical outcomes in patients with knee osteoarthritis undergoing corrective osteotomy with platelet-rich plasma or stromal vascular fraction post-treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657490/
https://www.ncbi.nlm.nih.gov/pubmed/36361627
http://dx.doi.org/10.3390/ijms232112835
work_keys_str_mv AT prizovaleksey differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT tchetinaelena differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT ereminilya differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT zagorodniynikolay differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT pulinandrey differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT belyakevgeniy differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT goncharovevgeniy differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT kotenkokonstantin differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT smyshlyaevivan differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT glukhovasvetlana differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments
AT lilaaleksandr differencesinsynovialcytokineprofileassociatedwithlongtermclinicaloutcomesinpatientswithkneeosteoarthritisundergoingcorrectiveosteotomywithplateletrichplasmaorstromalvascularfractionposttreatments